Serum interleukin 2-receptor levels in uveitis

References

• Smith K. A. T cell growth factor. Immunol. Rev 1980; 51: 337–357
   PubMed Web of Science ®Google Scholar
• Robb J. R., Munck R. A., Smith K. A. T cell growth factor receptors: quantitation, specifity and biological relevance. J. Exp. Med. 1981; 154: 1455–1474
   PubMed Web of Science ®Google Scholar
• Leonard W. J., Depper J. M., Robb R. J., Waldmann T. A., Greene W. C. Characterization of the human receptor for T-cell growth factor. Proc. Natl. Acad. Sci. USA 1983; 80: 6957–6961
   PubMed Web of Science ®Google Scholar
• Rubin L. A., Kurman C. C., Fritz M. E., Yarchoan R., Nelson D. L. Identification and characterization of a released form of interleukin-2-receptor. The Role of Leukocytes in Host Defense, J. J. Oppenheim. Liss, A.R., New York 1985
   Google Scholar
• Rubin L. A., Kurman C. C., Fritz M. E., Biddison W. E., Boutin B., Yarchoan R., Nelson D. L. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J. Immunol. 1985; 135: 3172–3177
   PubMed Web of Science ®Google Scholar
• Mingari M. C., Gerosa F., Carre G., Accolla R. S., Moretta A., Zubler R. H., Waldmann T. A., Moretta L. Human interleukin 2 promotes proliferation of activated B cells via surface receptors similiar to those of activated T cells. Nature 1984; 312: 641–643
   PubMed Web of Science ®Google Scholar
• Leonard W. J. Molecular and biochemical characterization of the human interleukin-2 receptor. Ann. Intern. Med 1986; 105: 560–572
   PubMedGoogle Scholar
• Symons J. A., Wood N. C., Di Giovine F. S., Duff G. W. Soluble IL-2 receptor in rheumatoid arthritis, correlation with disease activity, IL-1 and IL-2 inhibition. J. Immunol. 1988; 141: 2612–2613
   PubMed Web of Science ®Google Scholar
• Depper J. M., Leonard W. J., Kränke M., Noguchi P. D., Cunningham R. E., Waldmann T. A., Greene W. C. Regulation of interleukin 2 receptor expression: effects of phorbol diester, phospholipase c and reexposure to lectin or antigen. J. Immunol. 1985; 135: 3172–3177
   PubMedGoogle Scholar
• Rubin L. A., Jay G., Nelson D. L. The released interleukin 2 receptor binds interleukin 2 efficiently. J. Immunol. 1986; 137: 3841–3844
   PubMed Web of Science ®Google Scholar
• Sethi K. K., Naher M. Elevated titers of cell-free interleukin-2 receptor in serum and cerebrospinal fluid specimens of patients with acquired immunodefiency syndrome. Immunol. Lett. 1986; 13: 179–184
   PubMedGoogle Scholar
• Rubin L. A., Kurman C. C., Fritz M. E., Yarchoan R., Nelson D. L. Identification and characterization of a released form of the interleukin-2 receptor. The Role of Leukocytes in Host Defense, J. J. Oppenheim. Liss, A.R., New York 1985
   Google Scholar
• Nelson D. L. Soluble interleukin 2 receptors: analysis in normal individuals and in certain disease states. Fed. Proc. 1986; 45: 377–377
   Google Scholar
• Tung K. S.K., Umland E., Matzner P., Nelson K., Schauf V., Rubin L., Wagner D., Scollard D., Vithayasai P., Vithayasai V., Worobic S., Smith T., Suriyanond V. Soluble serum interleukin 2 receptor levels in leprosy patients. Clin. Exp. Immunol. 1987; 69: 10–15
   PubMed Web of Science ®Google Scholar
• Peacocke M., McLaughlin M. L., Levey A., Rubin L. A., Nelson D. L. Elevated serum levels of interleukin 2 receptors are present in patients maintained on chronic hemodialysis. Clin. Res. 1986; 34: 605–605
   Google Scholar
• Ching-Hon P., Stephen H. Jp., Kung P., Dodge R. K., Berard C. W., Crist W. M., Murphy S. B. High serum interleukin 2-receptor levels are related to advanced disease and a poor outcome in childhood non-Hodgkin's lymphoma. Blood 1987; 70: 624–628
   PubMedGoogle Scholar
• Wood N. C., Symons J. A., Duff G. W. Serum Interleukin-2 receptor in rheumatoid arthritis: a prognostic indicator of disease activity. Journal of Autoimmunity 1988; 1: 353–361
   PubMed Web of Science ®Google Scholar
• Campen D. H., Horwitz D. A., Quismorio F. P., jr., Ehresmann G. R., Martin W. J. Serum levels of interleukin 2-receptor and activity of rheumatic diseases characterized by immune system activation. Arthr. Rheumatism 1988; 31: 1358–1364
   PubMed Web of Science ®Google Scholar
• Kauhn L. S., Schlaegl T. F., Weber J. C., Biegel A. Serum immunoglobulins and uveitis. Arch. Ophthalmol. 1983; 101: 458–459
   PubMedGoogle Scholar
• Nussenblatt R. B., Salinas-Carmona M., Leake W., Scher J. T lymphocyte subsets in uveitis. Am. J. Ophthalmol. 1983; 95: 614–621
   PubMed Web of Science ®Google Scholar
• Snyder D. S., Tessler H. H., Yokoyoma M. M. Immunologic studies on Vogt-Koyanagi-Harada syndrome and pars planitis. Immunology and Immunopathology of the Eye, A. M. Silverstein, G. R. O'Connor. Masson, New York 1979; 68–75
   Google Scholar
• Murray P. J., Rahi A. New concepts in the control of ocular inflammation. Trans. Ophthalmol. Soc. UK 1985; 104: 152–158
   PubMedGoogle Scholar
• Grabner G., Berger R., Knapp W. Concanavalin A induced suppressor cell activity in inflammatory uveal disease. The Cornea in Health and Disease. Academic Press Inc. Ldt. and Royal Society of Medicine, London 1980; 487–491, ed. VIth Congress of the European Society of Ophthalmology
   Google Scholar
• Deschenes J., Char H. D., Kaleta S. Activated T lymphocytes in uveitis. Br. J. Ophthalmol. 1988; 72: 83–87
   PubMed Web of Science ®Google Scholar
• Nelson D. L., Rubin L. A., Kurman C. C., Fritz M. E., Boutin B. An analysis of the cellular requirements for the production of soluble interleukin-2 receptors in vitro. J. Clin. Immunol. 1986; 6: 114–120
   PubMed Web of Science ®Google Scholar
• Keystone E. C., Snow K. M., Bombardier C., Chang C. H., Nelson D. L., Rubin L. A. Elevated soluble interleukin 2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis. Arthritis and Rheumatism 1988; 31: 844–849
   PubMed Web of Science ®Google Scholar
• Van der Gaag R., Broersma L., Rothova A., Baarsma S., Kijlstra A. Immunity to a corneal antigen in Fuchs' heterochromic cyclitis patients. Invest. Ophthalmol. Vis. Sci. 1989; 30: 443–448
   PubMed Web of Science ®Google Scholar
• Murray P. J., Dinning W. J., Rahi A. H.S (1984) Contrasting relations between suppressor cell number and function in acute anterior uveitis and heterochromic cyclitis. Uveitis Update. Proceedings of the first international symposium on uveitis held in Hanasaari, EspooFinland, 1984, K. M. Saari. Excerpta medica, Amsterdam, New York, Oxford, 147–155
   Google Scholar
• Dernouchamps J. P (1984) Fuchs' heterochromic cyclitis: an IUSG study about 550 cases. Uveitis Update. Proceedings of the first international symposium on uveitis held in Hanasaari, EspooFinland, 1984, K. M. Saari. Excerpta medica, Amsterdam, New York, Oxford, 129–135
   Google Scholar